Skip to content

Clinical trials

Esophageal Squamous Cell Carcinoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Country / region: Italy Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20171
20182
20191
20202
20216
20222
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting6
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
Novartis Pharmaceuticals3
BeiGene2
Hoffmann-La Roche2
Alentis Therapeutics AG1
AstraZeneca1
Bayer1
Daiichi Sankyo1
European Institute of Oncology1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma22
Squamous Cell Carcinoma of Head and Neck8
Carcinoma, Non-Small-Cell Lung4
Esophageal Neoplasms3
Melanoma3
Stomach Neoplasms3
Triple Negative Breast Neoplasms3
Carcinoma, Hepatocellular2
Colorectal Neoplasms2
Endometrial Neoplasms2

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.